Alzheimer's Disease and the Key to Finding Better Treatments

https://is1-ssl.mzstatic.com/image/thumb/Podcasts115/v4/68/7f/a1/687fa17b-5209-2e3a-cc7b-1817064adc83/mza_15366389717892716428.jpg/600x600bb.jpg

Second Opinion LIVE!

ReachMD

50 episodes

8 months ago

Whether you're a dermatologist in Seattle, a family practitioner in New Mexico, or a trauma surgeon in New York City, the issues in health care today just can't wait. That's why you turn to ReachMD for Second Opinion Live: we're here to give you a chance to be heard.Join two of our seasoned physician hosts, Dr. Matt Birnholz and Dr. Michael Greenberg, for the next Second Opinion Live, airing on ReachMD.Do you have a topic suggestion or a story idea? Share them with us at info@reachmd.com.

Science

Medicine

RSS

All content for Second Opinion LIVE! is the property of ReachMD and is served directly from their servers with no modification, redirects, or rehosting. The podcast is not affiliated with or endorsed by Podjoint in any way.

Science

Medicine

Alzheimer's Disease and the Key to Finding Better Treatments

Second Opinion LIVE!

13 years ago

Alzheimer's Disease and the Key to Finding Better Treatments

Guest: Shellie Williams, MD
Guest: Reed Tuckson, MD
Host: Matt Birnholz, MD
Host: Michael Greenberg, MD

Currently more than 5.4 million Americans are living with Alzheimer's disease, a number that could triple by 2050 unless advances are made in early detection, treatments and prevention. Second Opinion Live hosts Dr. Michael Greenberg and Dr. Matt Birnholz discuss the many benefits for patients who receive an early diagnosis of Alzheimer's disease, one of which is the ability to participate in a clinical trial, with guest Dr. Shellie Williams from The University of Chicago Medical Center and the Alzheimer's Association.

Our Second Opinion Live hosts also discuss the latest national survey on the state of American Health with Dr. Reed Tuckson from the United Health Foundation.

Broadcast Funding for this program was provided in part by the Alzheimer's Association and its free nation-wide Alzheimer's clinical trials matching service - TrialMatch^TM.